Literature DB >> 16170944

The efficacy of naps as a fatigue countermeasure: a meta-analytic integration.

James E Driskell1, Brian Mullen.   

Abstract

Modern requirements for extended operations in aviation, transportation, the military, and industry have led to extensive research on countermeasures to mitigate the adverse effects of fatigue. The goals of this research were to (a) summarize and integrate existing research on naps as a fatigue countermeasure using meta-analysis, (b) identify the strength and significance of the effects of naps on performance and feelings of fatigue, and (c) identify factors that may moderate the effects of napping as a fatigue countermeasure. The results of these analyses can be used to predict nap efficacy as a function of length of the nap and the postnap interval. The results of these analyses also suggest an approach to work design that takes into account the optimal effects of naps as a fatigue countermeasure. Actual or potential applications of this research include the development of optimal work schedules to minimize fatigue and increase safety.

Entities:  

Mesh:

Year:  2005        PMID: 16170944     DOI: 10.1518/0018720054679498

Source DB:  PubMed          Journal:  Hum Factors        ISSN: 0018-7208            Impact factor:   2.888


  3 in total

1.  Sleep budgets in a globalizing world: biocultural interactions influence sleep sufficiency among Egyptian families.

Authors:  Carol M Worthman; Ryan A Brown
Journal:  Soc Sci Med       Date:  2012-05-14       Impact factor: 4.634

Review 2.  Findings from a systematic review of fatigue interventions: What's (not) being tested in mining and other industrial environments.

Authors:  Zoë Dugdale; Brianna Eiter; Cammie Chaumont Menéndez; Imelda Wong; Tim Bauerle
Journal:  Am J Ind Med       Date:  2022-02-19       Impact factor: 3.079

3.  Fatigue-related risk management in the emergency department: a focus-group study.

Authors:  Pierre Bérastégui; Mathieu Jaspar; Alexandre Ghuysen; Anne-Sophie Nyssen
Journal:  Intern Emerg Med       Date:  2018-05-18       Impact factor: 3.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.